The discovery of induced pluripotent stem cells (iPSCs) has made an invaluable contribution
to the field of regenerative medicine, paving way for identifying the true potential of human …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the coronavirus
disease 2019 (COVID-19), has provoked more than six million deaths worldwide and …

Airway–liquid interface cultures of primary epithelial cells and of induced pluripotent stem-
cell-derived airway epithelial cells (ALI and iALI, respectively) are physiologically relevant …

Induced pluripotent stem cells (iPSCs) generated from somatic cell sources are pluripotent
and capable of indefinite expansion in vitro. They provide an unlimited source of cells that …

The first line of antiviral immune response in the lungs is secured by the innate immunity.
Several cell types take part in this process, but airway macrophages (AMs) are among the …

Conjunctival epithelial cells, which express viral-entry receptors angiotensin-converting
enzyme 2 (ACE2) and transmembrane protease serine type 2 (TMPRSS2), constitute the …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused
a global economic and health crisis. Recently, plasma levels of galectin-9 (Gal-9), a β …

To minimize the global pandemic COVID-19 spread, understanding the possible
transmission routes of SARS-CoV-2 and discovery of novel antiviral drugs are necessary …

There is an urgent need to understand how SARS-CoV-2 infects the airway epithelium and
in a subset of individuals leads to severe illness or death. Induced pluripotent stem cells …

Human induced pluripotent stem cells (iPSC) have the potential to produce desired target
cell types in vitro and allow for the high-throughput screening of drugs/chemicals at …